National
Gay troops tell personal stories at Pentagon Pride
Event marks first such celebration since ‘Don’t Ask’ repeal
The personal story of a gay service member warmed the hearts of attendees during a panel discussion at the first ever Pentagon event celebrating June as Pride month.
Marine Corps Capt. M. Matthew Phelps, who serves as a commanding officer at the Marine Corps Recruit Depot in San Diego was among the three panelists who talked about the difficulties of serving in the closet before “Don’t Ask, Don’t Tell” was lifted.
Phelps said the situation was particularly difficult for him in 2007 when he was deployed to Iraq and fellow Marines would meet on Saturday to smoke cigars, watch movies and talk about their families at home.
“I sat there in the back of the room not talking to anybody because not only was it so hard to have left somebody at home — just like it was hard for everybody else — but when everyone was getting together and growing closer as a unit, by virtue of the fact that I wasn’t allowed to say anything, I was actually growing more distant from my unit,” Phelps said.
After graduating from the University of Rochester in November 2001 with a degree in applied music, Phelps said he enlisted in the Marine Corps after the terrorist attacks on Sept. 11, 2001, because he felt the need to serve his country. But Phelps said “Don’t Ask, Don’t Tell” was a strain on him until the ban was lifted on Sept. 20.
“I went into work on the 20th of September thinking that my life was going to change, and I went in and I sat down at my desk and I braced myself on the desk waiting for everyone to come and ask me if I was gay,” Phelps said. “Believe it or not, nobody did. I didn’t get any email. I didn’t get any phone call. In fact, the phone didn’t even ring. I was waiting — saying, ‘Please somebody talk to me today’ — because I felt like I was going to work for the very first time. For almost 10 years, Matthew was going to work as a Marine in uniform doing my job, doing the job that I thought I had been doing for 10 years, but I had only been half doing.”
Phelps was among the attendees at the White House Pride reception earlier this month where for the first time openly gay service members could participate while wearing their uniforms thanks to “Don’t Ask, Don’t Tell” repeal.
Others on the Pentagon panel, which was moderated by Pentagon Director of Press Operations Navy Capt. Jane Campbell were Gordon Tanner, the Air Force’s principal deputy general counsel, and Brenda “Sue” Fulton, a member of the board of visitors at the U.S. Military Academy at West Point and communications director for OutServe. All three panelists — Phelps an active duty troop, Tanner a civilian and Fulton a veteran — were gay and selected by word of mouth recommendations.
Tanner said he was supposed to distribute a list of benefits available to gay troops, but opted instead to encourage gay service members to serve as openly as possible because only that can help straight allies bridge their understanding of LGBT people.
“What I really want to talk about today is what each of us can do in our own day-to-day lives to make a difference,” Tanner said. “First of all, and most importantly, we need to be as visible as we can be. Everybody has a different comfort level. Everyone is in a different place. Let me encourage you to be as open and honest as you can possibly be.”
Fulton talked about the commitment she saw from straight allies in the military who wanted to make sure the transition to open service went smoothly and gay troops weren’t harmed. She described a commitment ceremony that took place over the weekend involving gay couples who served in the military.
“In the back of the church … was another chaplain, a senior chaplain Air Force O-6, Southern Baptist,” Fulton said. “I asked him why he was there and he said, ‘I just want to make sure everything goes smoothly for my airmen. I just want to make sure there aren’t any problems.'”
The one-hour event marks the first time that a Pride celebration has taken place for Defense Department personnel within the Pentagon. This is the first Pride month to have taken place since “Don’t Ask, Don’t Tell” was lifted from the books last year.
More than 350 attendees filled the Pentagon auditorium to capacity. The event was broadcast on the Pentagon channel and Tanner said during his remarks that troops as far away as Afghanistan were interested in watching a video of the event.
Attendees were made up of civilian Defense Department workers, service members who came in their uniforms and LGBT advocates who helped lead the way for “Don’t Ask, Don’t Tell” repeal. The program began after service members “presented the colors” and video messages were shown from President Obama and Defense Secretary Leon Panetta.
Defense Department General Counsel Jeh Johnson (Washington Blade file photo by Michael Key)
Delivering the keynote address at the event was Jeh Johnson, the Pentagon’s general counsel and co-chair of the Pentagon working group that wrote the report leading the way for legislative repeal of “Don’t Ask, Don’t Tell” in 2010. He spoke mostly of the process by which he and fellow co-chair Army Gen. Carter Ham, then commanding general of U.S. Army Europe, evaluated the risk of lifting the military’s gay ban.
While they pursued the task at hand without any predetermination on whether the ban should be repealed, Johnson said the group heard stories from gay service members who were eagerly awaiting an end to “Don’t Ask, Don’t Tell.”
“In communications with gay and lesbian current and former service members, we repeatedly heard a patriotic desire to serve and defend the nation subject to the same rules as everyone else,” Johnson said. “In the words of one gay service member, ‘Repeal would simply take a knife out of my back. You have no idea what it is like to serve in silence.'”
As a result of the process, Johnson said the institution of open service in the military has brought some isolated incidents, but “almost no issues or negative effects associated with repeal on unit cohesion, including within warfighting units.”
Even during his remarks, Johnson wouldn’t reveal his personal views on LGBT rights — saying he thinks as Pride is celebrated participants should remember the military is about Americans from a variety of backgrounds coming together to serve the country.
“Within the military, events such as this must occupy a different and qualified place because in the military, individual personal characteristics are subordinate to the good of the unit and the mission — service above self,” Johnson said. “From all that we learned in 2010 about the struggles and the sacrifice to remain in the military, I believe gay men and women in uniform readily agree with this.”
Johnson also said the Pentagon is examining ways to extend additional benefits to gay troops now that open service is in place. Pentagon officials have said they’ve been looking at these possible benefits since “Don’t Ask, Don’t Tell” was lifted last year.
Servicemembers Legal Defense Network and other LGBT groups have been pushing for benefits such as joint duty assignments, military family housing as well as access to certain family programs and free legal services. All are deemed by advocates to be within the authority of the Pentagon even with the Defense of Marriage Act in place.
“Going forward, the personnel and readiness community is now in the midst of reviewing which military family benefits can be extended to the partners and other family members of gay and lesbian service members,” Johnson said. “The repeal of ‘Don’t Ask, Don’t Tell’ exposes certain inequalities between similarly situated couples in the military community. This concerns many of our leaders. On the other hand, we must comply with current law, including the Defense of Marriage Act.”
Aubrey Sarvis, SLDN’s executive director, was among the attendees at the celebration and said he wished Johnson had “been more specific” in his remarks with regard to benefits.
“It’s just taking an inordinate amount of time to bring closure on this,” Sarvis said. “So, the day for a decision and an announcement by Secretary Panetta is here. In fact, it’s overdue.”
Sarvis added the decision to extend these benefits to gay troops should be resolved “within a matter of days,” but predicted more time will pass before an announcement is made.
Despite qualms about the lingering issue of benefits, Sarvis noted the historic nature of the Pride event.
“I think for all of these things to have happened in the past year — having finality on repeal, being here to celebrate — is something that many, many people could not have anticipated, so, yes, this is very much a historic occasion,” Sarvis said. “I think a number of people here are still pinching themselves.”
A number of gay service members who attended said they were elated being able to participate in the first Pride event at the Pentagon after the repeal of “Don’t Ask, Don’t Tell.”
Army Sgt. Bryan LaMadrid, 22, who’s gay, said coming to the event was particularly emotional for him.
“I’m stationed up at Ft. Meade right now, but I’m driving here and I’m kind of tearing up and have shivers going down my back and my neck because two years ago, you would have never imagined this, and now it’s happening this year,” LaMadrid said.
Navy Lt. Kevin Naughton, 32, who’s gay, was among those who helped plan the event and said “it was a big deal” to obtain approval from Panetta’s office to plan the Pride celebration.
“It was just an amazing process that we’ve gone through from going from repeal all the way to being able to have an event where we’re treated equally at work,” Naughton said.
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Kazakh president signs anti-LGBTQ propaganda bill
Top 10 LGBTQ local news stories of 2025
The 25 greatest queer movies of the 21st century so far
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
